CorticorpNews
Back to Science & Tech
Expand

Updated

Researchers at the Max Planck Institute for Biology of Ageing found that vitamin B12 largely corrected developmental defects in roundworms carrying a mutation in an RNA splicing gene linked to Verheij syndrome, a rare disorder causing developmental delays, impaired growth and short stature. Scientists found that vitamin B12 largely reversed developmental abnormalities in worms carrying a mutation linked to Verheij syndrome, a rare disorder causing growth problems and developmental delays. The mutant worms grew slowly and stayed smaller than normal, and the mutation disrupted vitamin B12-dependent metabolic pathways; adding vitamin B12 restored those pathways to normal. Researchers also examined public human cell datasets and collected blood samples from Verheij patients with Hormos Dafsari of the University Hospital Cologne, finding similar metabolic changes in humans. The researchers say the common vitamin could inspire new treatments for rare genetic diseases. ScienceDaily reported that the team has not yet established whether vitamin B12 supplementation improves symptoms in people with Verheij syndrome, and that more studies are needed to tell whether the worm benefits can become a patient treatment. The work also suggests metabolic disruption may contribute more to diseases caused by faulty RNA splicing than previously recognised.

Sources:ScienceDaily

1 outlet · 1 article · first seen Nov 16, 11:02 AM ET

Every source article